WO2020162020A1 - Dispositif de fourniture de médicament - Google Patents

Dispositif de fourniture de médicament Download PDF

Info

Publication number
WO2020162020A1
WO2020162020A1 PCT/JP2019/047821 JP2019047821W WO2020162020A1 WO 2020162020 A1 WO2020162020 A1 WO 2020162020A1 JP 2019047821 W JP2019047821 W JP 2019047821W WO 2020162020 A1 WO2020162020 A1 WO 2020162020A1
Authority
WO
WIPO (PCT)
Prior art keywords
drug
medicine
unit
control unit
detection
Prior art date
Application number
PCT/JP2019/047821
Other languages
English (en)
Japanese (ja)
Inventor
弘史 和田
Original Assignee
株式会社タカゾノ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 株式会社タカゾノ filed Critical 株式会社タカゾノ
Publication of WO2020162020A1 publication Critical patent/WO2020162020A1/fr

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms

Definitions

  • the present invention relates to a drug supply device.
  • Patent Document 1 As a prior document disclosing the configuration of the drug supply device, there is International Publication No. 2016/013553 (Patent Document 1).
  • the drug supply device described in Patent Document 1 includes a drug delivery unit including a first rotating body, a second rotating body, and a guide member.
  • the first rotating body has a circular surface that is rotatably arranged in a state of being inclined with respect to the horizontal plane.
  • the second rotating body is rotatably arranged on the outer peripheral side of the first rotating body and has an annular surface arranged on the horizontal plane.
  • the guide member is disposed above the circular surface of the first rotating body, extends in the radial direction with respect to the circular surface, and is located on the downstream side in the rotational direction of the first rotating body as it extends outward in the radial direction. It has a guide surface with which the medicine placed on the first rotating body can come into contact with the rotation of the one rotating body.
  • the drug supply device further includes a drug replenishment unit that replenishes the drug delivery unit with a drug.
  • the medicine replenishing unit can replenish the medicine based on the medicine replenishment status in the medicine delivering unit.
  • the drug supply device is required to reduce the time required to supply the drug.
  • the present invention has been made in view of the above problems, and an object of the present invention is to provide a drug supply device capable of shortening the time required to supply a drug.
  • the drug supply device includes a drug supply unit, a drug replenishment unit, a drug detection unit, and a control unit.
  • the medicine supply unit has a medicine receiving position for receiving the replenished medicine, conveys the medicine while aligning the medicine from the medicine receiving position, and supplies the medicines one by one from the top.
  • the medicine replenishing unit replenishes the medicine at the medicine receiving position.
  • the drug detection unit detects the presence or absence of a drug at the drug receiving position and outputs a drug detection signal.
  • the control unit controls the drug supplement unit.
  • the control unit receives the drug detection signal from the drug detection unit and controls the drug replenishment unit according to the drug detection signal.
  • the medicine detection unit has a first detection state in which the medicine is present at the medicine receiving position and a second detection state in which there is no medicine at the medicine receiving position.
  • the control unit causes the drug replenishment unit to stop replenishment of the drug when the drug detection unit is in the first detection state, and causes the drug replenishment unit to replenish the drug when the drug detection unit is in the second detection state.
  • control unit causes the drug replenishment unit to replenish the drug after a waiting time has elapsed from the time when the drug detection unit changed from the first detection state to the second detection state.
  • a drug information signal having drug information related to the shape of the drug is input to the control unit.
  • the control unit sets the waiting time according to the drug information.
  • control unit stops the replenishment of the drug by the drug replenishment unit when the drug detection unit changes from the second detection state to the first detection state, and the operation amount of the drug supply unit from that time point. Exceeds the set value, and the drug detection unit switches from the first detection state to the second detection state at a later time, the drug replenishment unit restarts replenishing the drug.
  • a drug information signal having drug information related to the shape of the drug is input to the control unit.
  • the control unit sets the set value according to the drug information.
  • the time required to supply a drug can be shortened.
  • FIG. 7 is a perspective view showing a state in which the opening/closing section is rotated upward and the discharge section is opened in the medicine supply unit included in the medicine supply device according to the embodiment of the present invention. It is a perspective view showing composition of a medicine storage container of a medicine replenishment part with which a medicine supply device concerning one embodiment of the present invention is provided.
  • FIG. 3 is a vertical cross-sectional view showing a state in which a lid is removed, in a drug container of a drug replenishing unit included in a drug supply device according to an embodiment of the present invention.
  • FIG. 3 is a partial perspective view showing the shape of the medicine replenishing unit included in the medicine supply device according to the embodiment of the present invention on the side of the opening of the medicine container. It is a partial perspective view which shows the structure of the base part with which the chemical
  • FIG. 4 is a front view showing a state in which a cover of a part of the base part is removed in a state where the drug supply part and the drug container are attached to the base part included in the drug supply device according to the embodiment of the present invention. It is a front side perspective view showing the state where a medicine storage container and a part of cover of a base part were removed from a medicine supply device concerning one embodiment of the present invention.
  • FIG. 1 is a perspective view showing the external appearance of a medicine packaging device according to an embodiment of the present invention.
  • FIG. 2 is a vertical cross-sectional view showing the configuration of the medicine packaging device according to the embodiment of the present invention.
  • FIG. 3 is a plan view of the medicine packaging device of FIG. 2 seen from the direction of arrow III. Note that FIG. 1 illustrates a state in which the door of the housing is open and the manual cassette is slid to the front side of the housing. In FIG. 3, the ceiling part of the medicine packaging apparatus is seen through.
  • a medicine packing apparatus 400 includes a medicine supply device unit, a housing 410, a rotating drum 420, a hopper 430, and a medicine packaging device unit 440. It has and.
  • the medicine packaging device 400 further includes a control device unit described later.
  • the drug supply device unit has a plurality of drug supply devices for supplying a drug.
  • the drug supply device unit includes a plurality of first drug supply devices 10, a plurality of second drug supply devices 20, and a third drug supply device 30.
  • Each of the plurality of second drug supply devices 20 accommodates a plurality of drugs and is configured to be able to supply the required number of drugs.
  • the second medicine supply device 20 is an automatic medicine supply cassette.
  • the third medicine supply device 30 is a manual medicine supply cassette.
  • the hand-delivered medicine supply cassette has compartments arranged in a matrix, and each compartment accommodates one package of medicine.
  • Each of the plurality of first drug supply devices 10 can supply the drug in place of the second drug supply device 20 of the plurality of second drug supply devices 20, which is empty of the drug. Further, each of the plurality of first drug supply devices 10 can supply another drug different from the drug contained in each of the plurality of second drug supply devices 20.
  • the drug supply device unit supplies the drug one by one from the drug supply device selected from the plurality of drug supply devices.
  • the medicine packaging device unit 440 packages the medicines supplied from the medicine supply device unit one by one.
  • the control device unit controls each of the medicine supply device unit and the medicine packaging device unit.
  • the housing 410 accommodates a drug supply device unit, a rotary drum 420, a hopper 430, and a drug packaging device unit 440.
  • the housing 410 has a door that can be opened and closed.
  • the operation panel 50 is provided on the front surface of the housing 410.
  • the rotary drum 420 is rotatably supported around the axis 4 in the housing 410.
  • a plurality of first drug supply devices 10 and a plurality of second drug supply devices 20 are attached to the rotary drum 420. That is, the first drug supply device 10 is housed in the housing 410 in a movable state.
  • the rotary drum 420 is provided with a drug delivery path 421.
  • the medicine transport path 421 is located above the hopper 430.
  • the first drug supply device 10 and the second drug supply device 20 are annularly arranged side by side on the outer peripheral side of the rotary drum 420.
  • the first drug supply device 10 and the second drug supply device 20 are arranged side by side in the vertical direction.
  • Each of the first drug supply device 10 and the second drug supply device 20 is connected to the drug delivery path 421.
  • the medicine supplied from each of the first medicine supply device 10 and the second medicine supply device 20 passes through the medicine conveyance path 421 and is put into the hopper 430.
  • the medicine supplied from the third medicine supply device 30 is put into the hopper 430.
  • the medicine put into the hopper 430 is packed in the medicine packing device unit 440.
  • each of the first drug supply device 10 and the second drug supply device 20 may be attached to a slidable rack instead of the rotating drum 420.
  • each of the first drug supply device 10 and the second drug supply device 20 can be moved to the outside of the casing 410 by pulling out the rack to the outside of the casing 410.
  • the sliding direction of the rack may be the front-rear direction of the housing 410 or the left-right direction of the housing 410.
  • the door of the housing 410 may have a double-door structure.
  • FIG. 4 is a front view showing the configuration of the drug supply device according to the embodiment of the present invention.
  • the first drug supply device 10 according to an embodiment of the present invention includes a drug supply module 100, which is a drug supply unit, and a drug replenishment unit 12.
  • the first medicine supply device 10 further includes a base unit 200.
  • a display unit 250 and a stop switch 238 are provided on the front surface of the base unit 200.
  • the medicine replenishing unit 12 includes a medicine storage container 300 that stores a medicine.
  • Each of the drug supply module 100 and the drug container 300 can be separately attached to and detached from the base unit 200.
  • FIG. 5 is a perspective view showing a configuration of a drug supply unit included in the drug supply device according to the embodiment of the present invention.
  • FIG. 6 is a plan view of the medicine supply unit of FIG. 5 viewed from the direction of arrow VI.
  • FIG. 7 is a perspective view of the medicine supply unit of FIG. 5 viewed from the arrow VII direction.
  • FIG. 8 is a diagram of the medicine supply unit of FIG. 5 viewed from the direction of arrow VIII.
  • FIG. 9 is a view of the medicine supply unit of FIG. 5 viewed from the arrow IX direction.
  • FIGS. 6 and 7 a lid portion described later is shown in a see-through manner.
  • a lid member and an opening/closing member which will be described later are not shown.
  • the lid portion is shown in a see-through manner, and the support portion described later is not shown.
  • a drug supply module 100 which is a drug supply unit included in the first drug supply device 10 according to an embodiment of the present invention, includes a rotating body 110, a peripheral wall part, and a discharge part 131. Equipped with.
  • the drug supply module 100 further includes a support part 150, a lid part 126, and an opening/closing part 141.
  • the drug supply module 100 has a drug receiving position and a discharging unit 131 for receiving the refilled drug, and conveys the drugs while aligning the drugs in a line from the drug receiving position to the discharging unit 131, and the discharging unit. It functions as a drug supply unit that sequentially discharges and supplies the drugs one by one from 131.
  • the drug supply module 100 is integrally configured by including the rotating body 110, the peripheral wall portion, the discharging portion 131, and the opening/closing portion 141.
  • the opening/closing unit 141 does not necessarily have to be provided. That is, the medicine supply module 100 may be integrally configured by including the rotating body 110, the peripheral wall portion, and the discharging portion 131.
  • FIG. 10 is a side view showing the configuration of the rotating body included in the drug supply unit included in the drug supply device according to the embodiment of the present invention.
  • the rotating body is shown when viewed from the same direction as in FIG. 9.
  • the rotating body 110 rotates about an axis 1 that extends in the vertical direction, and is coaxial with the axis 1 that is inclined downward as it goes radially outward about the axis 1. It has a conical slope 110s.
  • the rotating body 110 includes a first rotating portion 111 and a second rotating portion 112 that are coaxially arranged.
  • the second rotating portion 112 is located below the first rotating portion 111.
  • the side surface of the first rotating portion 111 and the side surface of the second rotating portion 112 form an inclined surface 110s.
  • Each of the first rotating unit 111 and the second rotating unit 112 is rotatably provided separately from each other. As shown in FIGS. 8 to 10, the first rotating portion 111 is connected to the first driven gear 111g.
  • the second rotating portion 112 is connected to the second driven gear 112g.
  • the slope 110s of the rotating body 110 is provided with a rolling prevention unit that prevents the medicine from rolling.
  • the rolling prevention portion is composed of a concave streak portion radially provided from the apex of the slope 110s.
  • the rolling prevention portion is composed of a first groove portion 111c provided on the first rotating portion 111 and a second groove portion 112c provided on the second rotating portion 112.
  • the rolling prevention unit does not necessarily have to be provided.
  • the rotating body 110 is rotatably supported by the supporting portion 150 located below the rotating body 110.
  • the rotating body 110 is provided so as to be attachable to and detachable from the supporting unit 150.
  • the support portion 150 includes a substantially circular horizontal plane portion 151, an upright portion 152 that stands up from the edge of the horizontal plane portion 151 in a substantially cylindrical shape, and a substantially cylindrical shape below the horizontal plane portion 151.
  • Each of the first driven gear 111g and the second driven gear 112g is located on the inner peripheral side of the base portion 153.
  • the drug supply module 100 includes a plurality of peripheral wall portions.
  • the medicine supply module 100 includes a first peripheral wall portion 121, a second peripheral wall portion 122, and a third peripheral wall portion 123.
  • the number of peripheral wall portions included in the drug supply module 100 is not limited to three and may be one or more.
  • each of the first peripheral wall portion 121, the second peripheral wall portion 122, and the third peripheral wall portion 123 extends in an arc shape along the circumferential direction about the axis 1 above the slope 110s. ing.
  • Each of the 1st peripheral wall part 121, the 2nd peripheral wall part 122, and the 3rd peripheral wall part 123 supports the chemical
  • the 1st peripheral wall part 121, the 2nd peripheral wall part 122, and the 3rd peripheral wall part 123 are located in a line with each other in the rotation direction 2 of the rotating body 110, and the peripheral wall part located in the downstream of the rotation direction 2 has the said radial direction. It is located outside and below.
  • the second peripheral wall portion 122 is located on the downstream side in the rotation direction 2 with respect to the first peripheral wall portion 121, and is radially outward and downward with respect to the first peripheral wall portion 121. Is located in.
  • the third peripheral wall portion 123 is located on the downstream side in the rotation direction 2 with respect to the second peripheral wall portion 122, and is located outside and below in the radial direction with respect to the second peripheral wall portion 122. ..
  • Each of the first peripheral wall portion 121 and the second peripheral wall portion 122 is located above the first rotating portion 111.
  • the third peripheral wall portion 123 is located above the second rotating portion 112. Therefore, the 1st rotation part 111 conveys the chemical
  • the first rotating unit 111 conveys the drug supported by the second peripheral wall 122 along the second peripheral wall 122.
  • the second rotating portion 112 conveys the medicine supported by the third peripheral wall portion 123 along the third peripheral wall portion 123.
  • each of the first peripheral wall portion 121, the second peripheral wall portion 122, and the third peripheral wall portion 123 is separated from the slope 110s.
  • each of the first peripheral wall portion 121, the second peripheral wall portion 122, and the third peripheral wall portion 123 has a slope 110 s within a range in which the medicine supplied onto the slope 110 s can be supported from the outside in the radial direction. Separated from each other.
  • the peripheral wall portions that are adjacent to each other in the rotational direction 2 are located on the downstream side in the rotational direction 2.
  • the end portion is separated from the slope 110s as it goes downstream in the rotation direction 2.
  • downstream end of the first peripheral wall portion 121 in the rotation direction 2 is separated from the slope 110s as it goes to the downstream side in the rotation direction 2.
  • downstream end of the second peripheral wall portion 122 in the rotation direction 2 is separated from the slope 110 s as it goes downstream in the rotation direction 2.
  • the peripheral wall portions adjacent to each other in the rotation direction 2 extend outward in the radial direction as they go downstream in the rotation direction 2. They are connected to each other by a slanted wall portion that descends.
  • the inclined wall portion does not necessarily have to be provided.
  • first peripheral wall portion 121 and the second peripheral wall portion 122 are connected to each other by the first inclined wall portion 124.
  • the second peripheral wall portion 122 and the third peripheral wall portion 123 are connected to each other by the second inclined wall portion 125.
  • each of the first inclined wall portion 124 and the second inclined wall portion 125 inclines toward the downstream side in the rotational direction 2 as it goes away from the slope 110s. Therefore, each of the boundary line between the first peripheral wall portion 121 and the first inclined wall portion 124 and the boundary line between the second peripheral wall portion 122 and the first inclined wall portion 124 increases with increasing distance from the slope 110s. , Is inclined to the downstream side in the rotation direction 2. Similarly, each of the boundary line between the second peripheral wall portion 122 and the second inclined wall portion 125 and the boundary line between the third peripheral wall portion 123 and the second inclined wall portion 125 is separated upward from the slope 110s. Therefore, it is inclined to the downstream side in the rotation direction 2.
  • each of the first peripheral wall portion 121, the second peripheral wall portion 122 and the third peripheral wall portion 123 is configured integrally with the lid portion 126. ..
  • Each of the first peripheral wall 121, the second peripheral wall 122, and the third peripheral wall 123 extends downward from the lower surface of the lid 126.
  • the lid 126 does not necessarily have to be provided, and the peripheral wall may be provided above the slope 110s.
  • Each of the first inclined wall portion 124 and the second inclined wall portion 125 is configured integrally with the lid portion 126. Each of the first inclined wall portion 124 and the second inclined wall portion 125 extends downward from the lower surface of the lid portion 126.
  • the lid 126 covers the slope 110s from above.
  • the lid 126 is provided so that the slope 110s can be opened upward.
  • the lid 126 is arranged on the support 150. Specifically, the lid 126 is provided on the lid member 120.
  • Each of the first peripheral wall portion 121, the second peripheral wall portion 122, and the third peripheral wall portion 123 is provided on the lid member 120.
  • Each of the first inclined wall portion 124 and the second inclined wall portion 125 is provided on the lid member 120.
  • the lid member 120 is detachably mounted on the support portion 150 with respect to the support portion 150.
  • a cushioning member 170 is provided between the lid 126 and the support 150.
  • the lid member 120 is placed on the horizontal surface portion 151 of the support portion 150 via the buffer member 170 having an arc shape.
  • the cushioning member 170 is made of an elastic body such as rubber.
  • the buffer member 170 does not necessarily have to be provided.
  • the lid member 120 is made of a transparent member. Therefore, each of the lid 126, the first peripheral wall 121, the second peripheral wall 122, and the third peripheral wall 123 is made of a transparent member. Thereby, the inside of the lid member 120 can be visually recognized from the outside of the lid member 120.
  • the lid member 120 may be made of a non-transparent member.
  • FIG. 11 is a perspective view showing an external appearance of a lid member included in a drug supply unit included in the drug supply device according to the embodiment of the present invention.
  • FIG. 12 is a view of the lid member of FIG. 11 viewed from the arrow XII direction.
  • FIG. 13 is a diagram of the lid member of FIG. 12 viewed from the arrow XIII direction.
  • FIG. 14 is a view of the lid member of FIG. 13 viewed from the arrow XIV direction.
  • FIG. 15 is a view of the lid member of FIG. 13 viewed from the arrow XV direction.
  • 11 and 12 show a state in which a later-described vibration transmission plate is removed from the lid member 120.
  • the lid member 120 is provided with the medicine supply hole 127, the cutout portion 128, and the attachment portion 129. Specifically, each of the medicine supply hole 127 and the attachment portion 129 is provided on the top surface of the lid member 120.
  • the cutout 128 is provided on the peripheral edge of the lid member 120 on the lower end side.
  • the drug supply hole 127 is provided to supply a drug from the outside of the lid member 120 to the inside of the lid member 120.
  • the cutout portion 128 is provided for disposing a discharge member, which will be described later, on the support portion 150.
  • the attachment portion 129 is provided to attach a vibration transmission plate, which will be described later, to the lid member 120.
  • the first peripheral wall portion 121 is located below the drug supply hole 127, and the first inclined wall portion 124 is located adjacent to the first peripheral wall portion 121. Then, the second peripheral wall portion 122 is positioned adjacent to the first inclined wall portion 124, the second inclined wall portion 125 is positioned adjacent to the second peripheral wall portion 122, and the second inclined wall portion 125 is adjacent.
  • the third peripheral wall portion 123 is located, and the cutout portion 128 is located adjacent to the third peripheral wall portion 123.
  • the mounting portion 129 is provided with a screw hole.
  • the vibration transmission plate 160 is fixed to the mounting portion 129 by screws.
  • the vibration transmission plate 160 constitutes a part of the lid 126.
  • the vibration transmission plate 160 is made of a magnetic material.
  • the vibration transmission plate 160 may be made of a non-magnetic material.
  • the vibration transmission plate 160 does not necessarily have to be provided.
  • a discharge member 130 is provided on the support portion 150 so as to be fitted into the cutout portion 128.
  • the discharge member 130 has an outer shape corresponding to the shape of the cutout 128.
  • a slight gap is provided between the discharge member 130 and the lid member 120.
  • the discharging member 130 discharges the medicine, which is sequentially conveyed along each of the first peripheral wall portion 121, the second peripheral wall portion 122, and the third peripheral wall portion 123, by the rotation of the rotating body 110 from the slope 110s. Is provided.
  • the discharge member 130 is provided with a standing wall portion 132. That is, the standing wall portion 132 is configured as a member different from the peripheral wall portion.
  • the standing wall portion 132 is provided between the third peripheral wall portion 123 and the discharge portion 131, and supports the medicine from the outside in the radial direction.
  • the standing wall portion 132 extends in an arc shape along the circumferential direction around the axis 1.
  • the third peripheral wall portion 123, the standing wall portion 132, and the discharge portion 131 are arranged along the circumferential direction centered on the axis 1.
  • the standing wall portion 132 does not necessarily have to be provided.
  • the discharge member 130 is provided with a pair of bearings 130b that supports a rotating shaft 140s that rotates the opening/closing part 141.
  • the pair of bearings 130b is erected at a position above the discharge part 131.
  • the opening/closing part 141 is configured to be able to open/close the discharging part 131 by being rotated by the rotating shaft 140s.
  • the opening/closing part 141 is connected to the biasing member 140t and is biased in the direction of closing the discharging part 131.
  • the biasing member 140t is composed of a torsion spring, but is not limited to the torsion spring.
  • the urging member 140t does not necessarily have to be provided.
  • the base unit 200 is provided with an open/close sensor 237 which will be described later and detects the open/closed state of the open/close unit 141.
  • the drug supply module 100 further includes a drug stopper 142.
  • the medicine stopping portion 142 is adjacent to the discharging portion 131 while extending in the radial direction along the slope 110s on the upstream side in the rotation direction 2 of the rotating body 110 with respect to the discharging portion 131.
  • the medicine stopper 142 is provided so as to be able to come into contact with and separate from the slope 110s.
  • the medicine stopping portion 142 is configured integrally with the opening/closing portion 141.
  • the medicine stopper 142 does not necessarily have to be provided.
  • FIG. 16 is a perspective view showing the outer appearance of the opening/closing member included in the drug supply unit included in the drug supply device according to the embodiment of the present invention.
  • FIG. 17 is a view of the opening/closing member of FIG. 16 seen from the direction of arrow XVII.
  • the opening/closing member 140 is provided with an opening/closing portion 141, a drug stopping portion 142, and a pair of engagement holes 140b.
  • the medicine stopping portion 142 projects from one edge in the width direction of the substantially flat plate-shaped opening/closing portion 141 so as to be orthogonal to the opening/closing portion 141.
  • the pair of engagement holes 140b are erected at a position above the opening/closing portion 141.
  • Each of the pair of engagement holes 140b has a D-shaped inner peripheral surface in a side view.
  • Each of the pair of engagement holes 140b engages with a portion of the rotating shaft 140s having a D-shaped cross section.
  • FIG. 18 is a perspective view showing a state in which the opening/closing section pivots upward and the discharge section is opened in the medicine supply unit included in the medicine supply device according to the embodiment of the present invention.
  • the medicine supply module 100 is illustrated when viewed from the same direction as FIG. 5.
  • the opening/closing member 140 rotates around the rotating shaft 140s, and the discharging portion 131 closed by the opening/closing portion 141 is opened. Then, the medicine stopper 142 is separated from the slope 110s.
  • the opening/closing member 140 rotates about the rotating shaft 140s, and the opening/closing part 141 closes the discharge part 131 and the medicine stopping part. 142 approaches the slope 110s.
  • FIG. 19 is a perspective view showing a configuration of a drug container of a drug replenishing unit included in the drug supply device according to the embodiment of the present invention.
  • FIG. 20 is a perspective view showing a state in which the outer lid is removed in the medicine container of the medicine replenishing unit included in the medicine supply device according to the embodiment of the present invention.
  • FIG. 21 is a perspective view showing a state in which the lid is removed in the medicine container of the medicine replenishing unit included in the medicine supply device according to the embodiment of the present invention.
  • FIG. 22 is a side view showing a state in which the lid is removed in the medicine container of the medicine replenishing unit included in the medicine supply device according to the embodiment of the present invention.
  • FIG. 20 is a perspective view showing a state in which the outer lid is removed in the medicine container of the medicine replenishing unit included in the medicine supply device according to the embodiment of the present invention.
  • FIG. 21 is a perspective view showing a state in which the lid is removed in the medicine container of the medicine replenishing unit included in the
  • FIG. 23 is a plan view showing a state in which the lid is removed in the drug container of the drug replenishing unit included in the drug feeding device according to the embodiment of the present invention.
  • FIG. 24 is a bottom view showing a state in which the lid is removed in the medicine container of the medicine replenishing unit included in the medicine supply device according to the embodiment of the present invention.
  • FIG. 25 is a vertical cross-sectional view showing a state in which the lid is removed in the medicine container of the medicine replenishing unit included in the medicine supply device according to the embodiment of the present invention.
  • the drug storage container 300 of the drug replenishing unit 12 included in the first drug supply device 10 has a bottomed cylindrical shape including a bottom and an opening. It also has a spiral groove formed on the inner peripheral surface thereof.
  • the drug container 300 includes a main body cylinder 310, a cylindrical portion 320, a bottom portion 330, and a lid portion 340.
  • the main body cylinder 310 has a spiral groove 312 formed on the inner peripheral surface thereof.
  • the main body cylinder 310 has a first opening 313 at one end and a second opening 314 at the other end.
  • the central axis of the main body cylinder 310 is located on the axis 3 of the medicine container 300. In FIG. 25, a vertical line 4 perpendicular to the axis 3 is shown.
  • the angle ⁇ formed by the perpendicular line 4 and the wall surface located on the side of the first opening 313 on the pair of wall surfaces facing each other of the spiral groove 312 formed on the inner peripheral surface of the main body cylinder 310 is
  • FIG. 26 is a partial perspective view showing the shape of the medicine replenishing section of the medicine supply device according to the embodiment of the present invention on the side of the opening of the medicine container. In FIG. 26, the state where the cylindrical portion 320 is removed from the main body cylinder 310 is shown.
  • the spiral groove 312 is formed on the inner peripheral surface of the main body cylinder 310 so as to continue until it reaches the first opening 313 of the main body cylinder 310.
  • a terminal end 312e of the spiral groove 312 on the first opening 313 side has a shape cut along the end surface of the main body cylinder 310 on the first opening 313 side.
  • the spiral groove 312 is formed on the inner peripheral surface of the main body cylinder 310 so as to continue to a position before reaching the second opening 314 of the main body cylinder 310.
  • the end of the spiral groove 312 on the second opening 314 side is connected to a circumferential groove 315 extending in the circumferential direction around the axis 3. Therefore, the groove width does not become narrow even in the vicinity of the second opening 314 of the main body cylinder 310. Therefore, it is possible to prevent the medicine from being clogged in the groove.
  • the cylindrical portion 320 is attached to the outer periphery of the main body cylinder 310 on the side of the first opening 313.
  • a male screw for attaching the lid 340 is formed on the outer circumference of the end of the cylindrical portion 320 on the side of the first opening 313 in the direction of the axis 3.
  • the bottom portion 330 is attached to the outer periphery of the main body cylinder 310 on the second opening 314 side.
  • the bottom portion 330 has a bottom surface 330b that closes the second opening 314.
  • the bottom surface 330b is curved in a convex shape on the side away from the second opening 314 in the axis 3 direction. That is, the inner bottom surface of the medicine container 300 has a convex curved surface shape on the outside of the medicine container 300.
  • the bottom portion 330 further has an annular portion 330c that protrudes annularly outward from the peripheral edge of the bottom surface 330b.
  • the identifier 331 is arranged in the space defined by the bottom surface 330b and the annular portion 330c.
  • the bottom portion 330 further includes a disc portion 332 that closes a space defined by the bottom surface 330b and the annular portion 330c.
  • the disc portion 332 is fixed to the bottom surface 330b with a screw.
  • the identifier 331 is sandwiched between the bottom surface 330b and the disc portion 332.
  • the identifier 331 is a permanent magnet.
  • the identifier 331 is formed so as to be different from each other in each of the plurality of drug storage containers 300. That is, each of the plurality of drug storage containers 300 has an identifier 331 that can identify each other.
  • the identifier 331 is not limited to the permanent magnet, and may be another magnetic body. Moreover, the identifier 331 does not necessarily have to be provided.
  • the lid 340 can close the first opening 313.
  • the lid portion 340 is composed of an outer lid 341 and an inner lid 342.
  • the outer lid 341 is rotatably provided with respect to the inner lid 342.
  • the outer lid 341 is provided with an arm portion 341a having a pair of engagement holes 341h.
  • a rotary shaft portion 342p having a pair of engagement protrusions 342s is provided on a side portion of the inner lid 342.
  • the pair of engagement holes 341h and the pair of engagement protrusions 342s are engaged with each other, whereby the arm portion 341a is supported rotatably around the rotation shaft portion 342p.
  • the outer lid 341 becomes rotatable with respect to the inner lid 342.
  • a plurality of openings 342h are formed on the inner lid surface 342c of the inner lid 342.
  • a space is formed between the outer lid 341 and the inner lid surface 342c for inserting the ear of a PTP (Press-Through-Package) packaging sheet of a desiccant or a medicine.
  • PTP Pressure-Through-Package
  • FIG. 27 is a partial perspective view showing the configuration of the base portion included in the drug supply device according to the embodiment of the present invention.
  • FIG. 28 is a partial rear view showing the configuration of the base portion included in the drug supply device according to the embodiment of the present invention.
  • FIG. 29 is a partial perspective view showing a state in which the drug supply unit included in the drug supply device according to the embodiment of the present invention is mounted on the base unit.
  • the base unit 200 includes a first drive shaft 210, a second drive shaft 240, a discharge chute 220, a first sensor 231 which is a first detection unit, and a second detection unit which is a second detection unit.
  • Two sensors 232, a drug detection sensor 235 which is a drug detection unit, and a vibration unit 260 are provided.
  • the base unit 200 is provided with a first motor that is a first drive source that drives the rotating body 110 and a second motor that is a second drive source that drives the opening/closing unit 141.
  • Each of the first sensor 231, the second sensor 232, the drug detection sensor 235, and the vibrating section 260 may not necessarily be provided.
  • the first drive shaft 210 is connected to the first motor.
  • the first drive shaft 210 extends upward from the bottom portion of the base portion 200.
  • a first drive gear 211g and a second drive gear 212g are provided at the tip of the first drive shaft 210.
  • the first drive gear 211g engages with the first driven gear 111g.
  • the second drive gear 212g engages with the second driven gear 112g.
  • the first rotating portion 111 rotates via the first drive gear 211g and the first driven gear 111g, and the second drive gear 212g and the second drive gear 212g.
  • the second rotating portion 112 rotates via the driven gear 112g. That is, each of the first rotating unit 111 and the second rotating unit 112 is driven by the common drive source.
  • the rotation speed of the second rotation unit 112 is higher than the rotation speed of the first rotation unit 111.
  • the number of teeth of each of the first drive gear 211g, the second drive gear 212g, the first driven gear 111g, and the second driven gear 112g is such that the rotation speed of the second rotating portion 112 is equal to that of the first rotating portion 111. It is set to be higher than the rotation speed.
  • the second drive shaft 240 is connected to the second motor.
  • the second drive shaft 240 extends substantially horizontally from one side portion of the base portion 200 toward the other side portion.
  • the tip of the second drive shaft 240 engages with the rotating shaft 140s.
  • the second motor drives and the second drive shaft 240 rotates, so that the opening/closing member 140 rotates together with the rotating shaft 140s.
  • each of the opening/closing unit 141 and the medicine stopping unit 142 also rotates about the rotation shaft 140s. In this way, each of the opening/closing section 141 and the medicine stopping section 142 is driven by the common drive source.
  • the discharge chute 220 guides the medicine discharged from the discharge part 131 to the outside of the base part 200.
  • the inlet of the discharge chute 220 faces the discharge part 131.
  • the first sensor 231 is arranged adjacent to the discharging unit 131.
  • a second sensor 232 is arranged on the discharge chute 220. The second sensor 232 is located farther from the discharge unit 131 than the first sensor 231.
  • the first sensor 231 detects that the medicine on the slope 110s has been discharged from the discharge portion 131.
  • the first sensor 231 outputs a first detection signal when detecting that the medicine has reached the first detection position outside the discharging unit 131.
  • the first sensor 231 is composed of a photoelectric sensor and has a light projecting unit and a light receiving unit which are arranged so as to sandwich the region immediately downstream of the discharge unit 131 between them. The arrival of the drug discharged from the discharge unit 131 is detected by detecting that the optical axis between the light projecting unit and the light receiving unit is blocked by the drug.
  • the second sensor 232 detects the drug discharged from the discharge unit 131.
  • the second sensor 232 outputs a second detection signal when it is detected that the medicine has passed a second detection position which is far from the medicine supply module 100 from the first detection position.
  • the second sensor 232 is composed of a photoelectric sensor and has a light projecting unit and a light receiving unit which are arranged so as to sandwich the drug passage defined by the discharge chute 220 therebetween.
  • the passage of the medicine discharged from the discharging portion 131 is detected by detecting that the optical axis between the light projecting portion and the light receiving portion has returned from the state blocked by the medicine to the original opened state.
  • the drug detection sensor 235 detects the presence or absence of a drug at the drug receiving position on the slope 110s of the drug supply module 100 and outputs a drug detection signal.
  • the drug detection sensor 235 is composed of a photoelectric sensor and has a light projecting unit and a light receiving unit which are arranged so as to sandwich the region below the drug supply hole 127 between them. That is, the region located below the drug supply hole 127 on the slope 110s is the drug receiving position for receiving the refilled drug.
  • the drug detection sensor 235 detects the presence or absence of a drug at the drug receiving position by detecting whether or not the optical axis between the light projecting unit and the light receiving unit is blocked by the drug.
  • the drug detection sensor 235 has a first detection state in which it is detected that there is a drug at the drug receiving position, and a second detection state in which it is detected that there is no drug at the drug receiving position.
  • the lid member 120 at least a portion on the optical axis is transparent.
  • the vibrating section 260 vibrates each of the first peripheral wall section 121, the second peripheral wall section 122, and the third peripheral wall section 123.
  • the vibrating section 260 vibrates each of the first peripheral wall section 121, the second peripheral wall section 122, and the third peripheral wall section 123 via the lid section 126.
  • the vibration unit 260 is provided so as to be located directly above the vibration transmission plate 160.
  • the vibrating section 260 is provided with a permanent magnet (not shown).
  • the vibration transmission plate 160 is made of a magnetic material.
  • the vibrating section 260 and the vibration transmitting plate 160 are attracted to each other by the magnetic force of the permanent magnet. That is, the contact portions of the vibrating portion 260 and the lid portion 126 are attracted to each other by the magnetic force.
  • the vibration of the vibrating section 260 propagates to each of the first peripheral wall section 121, the second peripheral wall section 122, and the third peripheral wall section 123 through the lid section 126.
  • the vibrating section 260 vibrates in a direction inclined with respect to the horizontal plane.
  • the vibrating section 260 is driven by an eccentric motor 273 described later in which the motor shaft is arranged so as to be inclined with respect to the horizontal plane.
  • the vibration is generated.
  • the vibration caused by the portion 260 does not directly propagate to the standing wall portion 132.
  • a cushioning member may be provided at the connection between the vibrating section 260 and the base section 200 to suppress the vibration from the vibrating section 260 from propagating to the base section 200. Accordingly, it is possible to suppress the vibration from the vibrating section 260 from propagating to the standing wall section 132 through the base section 200 and the supporting section 150.
  • the vibration part 260 is provided in the base part 200, and the lid part 126 is provided in the drug supply module 100, so that the vibration is generated.
  • the part 260 can be brought into and out of contact with the lid part 126.
  • the base unit 200 is provided with a module detection sensor 236 which will be described later and detects that the medicine supply module 100 is attached.
  • FIG. 30 is a front view showing a state in which a cover of a part of the base part is removed in a state where each of the drug supply part and the drug storage container is attached to the base part included in the drug supply device according to the embodiment of the present invention. It is a figure.
  • FIG. 31 is a front side perspective view showing a state in which the medicine container and the partial cover of the base portion are removed from the medicine supply device according to the embodiment of the present invention.
  • FIG. 32 is a rear perspective view showing a state in which the other part of the cover of the base part is removed from the drug supply device according to the embodiment of the present invention.
  • the drug container 300 is attached to the base part 200 with the lid part 340 removed.
  • the medicine container 300 attached to the base portion 200 is located above the medicine supply module 100.
  • the axis 3 of the medicine container 300 is inclined with respect to the horizontal plane.
  • the axis 3 of the medicine container 300 is inclined by 20° with respect to the horizontal plane.
  • the base portion 200 is provided with four roller portions that support the medicine container 300 so as to be rotatable about the axis 3.
  • the base portion 200 is provided with a pair of rotating shafts.
  • a pair of roller portions 281 are attached to one of the pair of rotating shafts with a space therebetween.
  • a pair of roller portions 282 are attached to the other of the pair of rotating shafts with a space therebetween.
  • the base unit 200 is provided with a container detection sensor 233 that detects that the medicine container 300 is attached.
  • a path 290 is provided in the base part 200.
  • the base unit 200 is provided with an identification sensor 234 that recognizes the identifier 331 of the drug container 300.
  • the identification sensor 234 is a magnetic sensor.
  • the identification sensor 234 is not limited to the magnetic sensor and may be any sensor that can recognize the identifier 331. Further, the identification sensor 234 does not necessarily have to be provided.
  • the first motor 270 which is the first drive source for driving the rotating body 110 and the second motor source 270 which is the second drive source for driving the opening/closing unit 141 are provided.
  • a motor 271 is provided.
  • the base portion 200 is provided with a third motor 272 that is a third drive source that drives the other of the pair of rotating shafts.
  • the drug replenishing unit 12 shown in FIGS. 4 and 30 includes a drug container 300, the above-mentioned pair of rotary shafts, a pair of roller units 281, a pair of roller units 282, a third motor 272, a container detection sensor 233, and An identification sensor 234 is included.
  • the drug storage container 300 stores a drug and is driven to refill the drug receiving position of the drug supply module 100 with the drug. That is, the medicine replenishing unit 12 replenishes the medicine at the medicine receiving position.
  • a display unit 250 is provided on the front surface of the base unit 200.
  • the display unit 250 selectively emits light of one color from a plurality of colors. Further, the display unit 250 can also emit blinking light.
  • the light emission pattern of the display unit 250 can indicate the state of the first medicine supply device 10.
  • FIG. 33 is a block diagram showing a connection system of the medicine packaging device according to the embodiment of the present invention.
  • the medicine packaging device 400 according to the embodiment of the present invention includes a main control unit 41.
  • the main controller 41 is electrically connected to each of the medicine packaging device unit 440, the medicine supply device unit 450, and the operation panel 50.
  • the main controller 41 is electrically connected to a prescription information receiving device 90 that receives prescription information via the operation panel 50.
  • FIG. 34 is a block diagram showing a connection system of the drug supply device according to the embodiment of the present invention.
  • the first drug supply device 10 according to one embodiment of the present invention has a control unit 11 that controls each of the drug supply module 100, which is a drug supply unit, and the drug replenishment unit 12. ..
  • the control unit 11 is provided in the base unit 200.
  • the control unit 11 includes the first sensor 231, the second sensor 232, the container detection sensor 233, the identification sensor 234, the drug detection sensor 235, the module detection sensor 236, the open/close sensor 237, the stop switch 238, the display unit 250, and the first motor 270.
  • the second motor 271, the third motor 272, and the eccentric motor 273 are electrically connected.
  • the control unit 11 is electrically connected to the main control unit 41.
  • a control device unit 460 is configured by the control unit 11 of each of the plurality of first drug supply devices 10 and the main control unit 41.
  • the medicine packaging device 400 includes the control device unit 460.
  • the operation of the first drug supply device 10 according to the embodiment of the present invention will be described below. First, the operation of the drug supply module 100, which is a drug supply unit, will be described.
  • the medicine supplied from the medicine supply hole 127 to the inside of the lid member 120 is received at the medicine receiving position on the slope 110s and is supported by the first peripheral wall portion 121.
  • Each of the first rotating unit 111 and the second rotating unit 112 is driven by the first motor 270.
  • the medicine supported by the first peripheral wall portion 121 is conveyed along the first peripheral wall portion 121.
  • the medicines supported by the first peripheral wall portion 121 are aligned along the first peripheral wall portion 121 while being transported along the first peripheral wall portion 121.
  • the medicine supported by the first peripheral wall portion 121 sequentially moves downward from the medicine located on the leading side in the rotation direction 2 along the first inclined wall portion 124 and moves outward in the radial direction around the axis 1. By doing so, it is supported by the second peripheral wall portion 122.
  • the medicine that descends along the first inclined wall portion 124 is accelerated by gravity, and thus has a higher moving speed than the medicine that is conveyed along the first peripheral wall portion 121. As a result, the distance between the medicine that has descended along the first inclined wall portion 124 and the medicine that has not yet descended along the first inclined wall portion 124 becomes wider.
  • the medicine supported by the second peripheral wall portion 122 is conveyed along the second peripheral wall portion 122.
  • the medicine supported by the second peripheral wall portion 122 sequentially moves downward from the medicine located on the leading side in the rotation direction 2 along the second inclined wall portion 125 and moves to the outer side in the radial direction, thereby the third medicine. It is supported by the peripheral wall portion 123.
  • the medicine that descends along the second inclined wall portion 125 is accelerated by gravity, and therefore has a higher moving speed than the medicine that is conveyed along the second peripheral wall portion 122. As a result, the interval between the medicine that has descended along the second inclined wall portion 125 and the medicine that has not yet descended along the second inclined wall portion 125 becomes wider.
  • the medicine supported by the third peripheral wall portion 123 is conveyed along the third peripheral wall portion 123. Since the rotation speed of the second rotating portion 112 is higher than the rotation speed of the first rotating portion 111, the distance between the medicine supported by the third peripheral wall portion 123 and the medicine supported by the second peripheral wall portion 122 is small. Get wider
  • the medicines supported by the third peripheral wall 123 are sequentially supported by the standing wall 132 from the medicine located on the leading side in the rotation direction 2.
  • the medicine supported by the standing wall portion 132 is conveyed along the standing wall portion 132.
  • the medicine stopping portion 142 When the medicine stopping portion 142 is close to the slope 110s, the medicine conveyed along the standing wall portion 132 is prevented from moving to the discharging portion 131. Therefore, the rotation shaft 140s is rotated by the second motor 271.
  • the opening/closing member 140 When the rotating shaft 140s is rotated to one side, the opening/closing member 140 is rotated around the rotating shaft 140s, the discharging portion 131 closed by the opening/closing portion 141 is opened, and the medicine stopping portion 142 is opened. It is separated from the slope 110s. As a result, among the medicines supported by the standing wall portion 132, the medicines located on the leading side in the rotation direction 2 are discharged one by one from the discharge portion 131.
  • the first sensor 231 detects that the medicine on the slope 110s is discharged from the discharge portion 131.
  • the second sensor 232 detects the drug discharged from the discharging unit 131.
  • the rotating shaft 140s is rotated to the other side, whereby the opening/closing member 140 is rotated around the rotating shaft 140s, and the discharge portion 131 is closed by the opening/closing portion 141.
  • the drug stopper 142 approaches the slope 110s.
  • the medicine supported by the upright wall portion 132 is prevented from moving to the discharging portion 131 by the medicine stopping portion 142, and is prevented from being discharged from the discharging portion 131 by the opening/closing portion 141.
  • the opening/closing unit 141 is in the open state when the drug is supplied from the drug supply unit, and is in the closed state when the drug is not supplied from the drug supply unit.
  • the medicine supply unit moves with respect to the housing 410, the medicine supply unit is stopped and the opening/closing unit 141 is closed, and then the movement of the medicine supply unit is started. In this case, it is possible to suppress the discharge of the undesired drug from the discharge unit 131 during the movement of the drug supply unit.
  • the opening/closing unit 141 When resuming the supply of the drug from the drug supply unit, the opening/closing unit 141 is opened and the drug supply unit is restarted. In this case, the drug can be discharged from the discharge unit 131 immediately after the drug supply unit is restarted.
  • the medicine replenishing unit 12 By rotating the pair of roller portions 282 by the third motor 272, the medicine container 300 is rotationally driven around the axis 3.
  • the medicine in the medicine container 300 is conveyed from the bottom 330 side of the medicine container 300 to the first opening 313 side by the spiral groove 312, and the first opening 313 is formed. It is discharged from the section 313.
  • the medicine discharged from the first opening 313 passes through the connection conduit 290 of the base 200 and is supplied into the medicine supply hole 127 of the lid member 120.
  • the medicines supplied into the medicine supply holes 127 of the lid member 120 are discharged one by one from the discharge portion 131 of the medicine supply module 100.
  • the base portion 200 is attached with one medicine container 300 selected in sequence from a plurality of medicine containers 300.
  • Each of the plurality of drug storage containers 300 is driven under different drive conditions set based on the identifier 331.
  • the drug supply unit is driven corresponding to each of the plurality of drug storage containers 300.
  • drugs there are two types of drugs: general drugs, which are small tablets, and special drugs, such as capsules, long and thin tablets, spherical tablets, and triangular column tablets.
  • a general medicine or a special medicine is stored in each of the plurality of medicine storage containers 300.
  • the control unit 11 to which the detection signal of the identifier 331 from the identification sensor 234 is input is housed inside the medicine container 300 attached to the base unit 200.
  • Determine the type of drug present That is, the control unit 11 is input with a drug information signal including drug information regarding the shape of the drug, which is included in the detection signal of the identifier 331 from the identification sensor 234.
  • FIG. 35 is a time chart when the medicine packaging device according to an aspect of the present invention operates according to prescription information.
  • FIG. 36 is a diagram for explaining prescription information and packaging information.
  • prescription information is input to the prescription information reception device 90.
  • the prescription information includes information such as the type of drug, time of administration, number of days of administration, daily dose, and dose at each time of administration.
  • the drug for 3 days is prescribed in one prescription
  • the required number of drug A in one prescription is 9
  • the required number of drug B in one prescription is 6 Is.
  • the required number of drug A is one after breakfast, after lunch, and after dinner.
  • the required number of B drugs is 0 after breakfast and after dinner, and 2 after lunch.
  • one packaging information is created based on one prescription information.
  • one prescription corresponds to one packaging information based on one prescription information.
  • multiple packaging information may be created based on one prescription information.
  • one prescription information includes three kinds of medicines
  • first packaging information is created for two kinds of the three kinds of medicines
  • second packaging information for the remaining one kind. May be created.
  • each of the created plurality of packaging information corresponds to one prescription here.
  • one packaging information may be created based on a part of one prescription information. For example, when one prescription information includes three kinds of medicines, one packaging information may be created for two kinds of the three kinds of medicines and the packaging information may not be created for the remaining one kind of medicines. is there. In this case, one piece of created packaging information corresponds to one prescription here.
  • the prescription information reception device 90 inputs the packaging information according to the input prescription information into the operation panel 50.
  • the packaging information includes information for packaging the medicine according to the prescription information.
  • a packing instruction for causing the medicine packing apparatus 400 to start the packing operation is input from the input unit provided on the operation panel 50.
  • the packing information including the selection information is input from the operation panel 50 to the main control unit 41.
  • the main control unit 41 to which the packaging information including the selection information is input, inputs the required number of drugs in one prescription to the control unit 11 of the first drug supply device 10 selected by the selection information.
  • the packaging information signal having the packaging information of the medicine is input to the control device unit 460 including the control unit 11 and the main control unit 41 of each of the plurality of first drug supply devices 10.
  • the required number of medicines in one package and the supply instruction for starting the supply operation are sequentially input from the main control unit 41 to the control unit 11 at appropriate timing.
  • the control unit 11 executes the supply operation for one package.
  • a notification of the completion is input from the control unit 11 to the main control unit 41.
  • FIG. 37 is a flow chart for explaining the operation of the control unit of the drug supply device, in which the required number of drugs in one prescription is input from the main control unit.
  • the drug storage container 300 is identified by the input signal from the identification sensor 234. (Step S11).
  • the control unit 11 that has identified the medicine container 300 causes the medicine replenishment unit 12 to start replenishment of the medicine (step S12).
  • FIG. 38 is a flow chart for explaining the operation of the control unit when the medicine is replenished by the medicine replenishing unit.
  • the control unit 11 determines whether the supply number is less than the required number of medicines in one prescription after starting the medicine replenishment by the medicine replenishment unit 12 (step S12) (step S12). S21).
  • the control unit 11 of the first drug supply device 10 in which the drug storage container 300 that stores the A drug is mounted indicates that the supply number of the A drug is It is determined whether the required number is less than 9.
  • the control unit 11 of the first drug supply device 10 in which the drug storage container 300 containing the B drug is mounted determines whether the number of supplies of the B drug is less than the required number of 6.
  • the control unit 11 determines from the medicine detection signal whether the medicine detection sensor 235, which is a medicine detection unit, detects that there is a medicine at the medicine receiving position. (Step S22).
  • the control unit 11 stops the third motor 272, which is a replenishing motor, when the medicine detection sensor 235 is in the first detection state in which the medicine is detected at the medicine receiving position (step S23). That is, the control unit 11 causes the drug replenishment unit 12 to stop refilling the drug when the drug detection unit is in the first detection state. After that, the control unit 11 returns to step S21.
  • the third motor 272 which is a replenishing motor
  • the control unit 11 rotates the third motor 272 in the forward rotation direction in the second detection state in which the medicine detection sensor 235 detects that there is no medicine at the medicine receiving position (step S24). That is, the control unit 11 causes the drug replenishment unit 12 to replenish the drug when the drug detection unit is in the second detection state. After that, the control unit 11 returns to step S21.
  • control unit 11 receives the drug detection signal from the drug detection unit and controls the drug replenishment unit 12 according to the drug detection signal.
  • the control unit 11 may be configured to cause the drug replenishment unit 12 to replenish the drug after a waiting time has elapsed from the time when the drug detection unit changed from the first detection state to the second detection state.
  • the control unit 11 receives the drug information signal including the drug information regarding the shape of the drug, which is included in the detection signal of the identifier 331 from the identification sensor 234.
  • the control unit 11 sets the waiting time according to the drug information.
  • the control unit 11 rotates the third motor 272 in the reverse direction (step S25). Thereby, the medicine contained in the medicine container 300 can be returned to the inside of the medicine container 300 from the first opening 313 side.
  • the control unit 11 stops the third motor 272 after a lapse of a certain time after rotating the third motor 272 in the reverse direction (step S26).
  • control unit 11 causes the drug replenishment unit 12 to replenish the drug when the drug detection unit changes from the second detection state to the first detection state in a state where the number of supplies is less than the required number of drugs in one prescription. It is the later one of the time when the operation amount of the drug supply unit exceeds the set value from the time of stopping and the first detection state and the time when the drug detection unit changes from the first detection state to the second detection state.
  • the medicine replenishment unit 12 may be configured to restart the medicine replenishment at the time point. In this case, the control unit 11 sets the set value according to the drug information.
  • the operation amount of the drug supply unit is the cumulative rotation angle of the first rotation unit 111 in the rotation direction 2 of the drug supply unit from the time when the first detection state is reached, or the rotation of the first rotation unit 111. It is the cumulative drive time in the direction 2.
  • the set value of the cumulative rotation angle is, for example, 60°.
  • the set value of the cumulative drive time is a drive time required for the cumulative rotation angle to be, for example, 60°.
  • the above replenishment operation is performed at any time in each of the plurality of first drug supply devices 10 that supplies the drug necessary for one prescription.
  • the control device unit 460 in the first drug supply device 10 that supplies the drug next to the first drug supply device 10 that is supplying the drug, according to the packaging information, the drug supply unit.
  • the medicine replenishment unit 12 starts replenishment of the medicine before the first operation start time.
  • the control unit 11 of the first medicine supply apparatus 10 causes the medicine replenishment unit 12 to start replenishment of the medicine when the required number of medicines in one prescription is input from the main control unit 41.
  • the control unit 11 of the first medicine supply apparatus 10 causes the medicine replenishment unit 12 to start replenishment of medicines even if the supply instruction is not input from the main control unit 41.
  • the control device unit 460 for example, the first medicine supply device 10 that supplies the medicine A has 3 days from the first day to the third day after breakfast. While supplying the drug A for the package, the first drug supply device 10 for supplying the drug B for the three packages from the first day to the third day after lunch is next tested.
  • the medicine replenishment unit 12 starts the medicine replenishment before the time when the 1-motor 270 starts driving.
  • the medicine replenishing unit 12 has completed the first replenishment at the time when the first medicine supplying apparatus 10 that supplies the medicine next starts to supply the medicine, and the medicine is in the medicine receiving position. Has become.
  • the control device unit 460 stops the drug replenishment by the drug replenishment unit 12 sequentially from the first drug supply device 10 which has finished supplying the required number of drugs in one prescription according to the packaging information.
  • the control device unit 460 finishes the supply of the B medicine necessary for the three packages from the first day to the third day after lunch,
  • the replenishment of the B medicine by the medicine replenishing unit 12 of the first medicine supplying apparatus 10 which has finished supplying the required number of B medicines in the prescription is stopped.
  • the controller unit 460 then completes the supply of the A drug necessary for the 3 packages from the first day to the third day after dinner, and then supplies the necessary number of A drugs in one prescription.
  • the replenishment of the medicine A by the medicine replenishing unit 12 of the supply device 10 is stopped.
  • FIG. 39 is a flowchart for explaining the operation of the control unit of the drug supply device, which is input with the required number of drugs and the supply instruction of the drug from the main control unit.
  • the discharge unit that is blocked by the opening/closing unit 141. 131 is opened (step S31).
  • the control unit 11 After opening the discharge unit 131, the control unit 11 causes the drug supply module 100, which is a drug supply unit, to start supplying the drug in one package (S32). After starting the supply of the medicine by the medicine supply module 100 (step S32), the control unit 11 counts the medicines supplied from the medicine supply module 100 (step S33). When the number of medicines supplied exceeds the necessary number of medicines in one package, the medicine supply by the medicine supply module 100 is terminated (step S34).
  • the control unit 11 determines whether or not the number of medicines supplied is equal to or larger than the necessary number of medicines in one prescription (step S35). When the supply number is more than the required number of medicines in one prescription, the opening/closing section 141 closes the discharge section 131 (step S36). When the supply number is less than the required number of medicines in one prescription, the control unit 11 ends the operation of supplying one package of medicine while maintaining the discharge unit 131 in an open state.
  • FIG. 40 is a flow chart for explaining the operation of the control unit when a drug is supplied by the drug supply unit. As shown in FIG. 40, the control unit 11 determines whether the supply number is less than the required number of drugs in one package after starting the supply of the drug by the drug supply module 100 (step S32) (step S32). S41).
  • the first drug supply device 10 in which the drug container 300 containing the drug A is mounted determines whether the supply number of the A medicine is less than the required number of 1.
  • the control unit 11 of the first drug supply device 10 in which the drug storage container 300 that stores the B drug is mounted determines whether the supply number of the B drug is less than the required number of 2.
  • the control unit 11 drives the first motor 270, which is a supply motor, in the forward rotation direction, and also drives the eccentric motor 273, which is a vibration motor ( Step S42). As a result, each of the first rotating portion 111 and the second rotating portion 112 rotates in the forward rotation direction and the vibrating portion 260 vibrates.
  • control unit 11 determines whether or not the first sensor 231 which is the first detection unit has detected the drug based on the presence or absence of the input of the first detection signal from the first sensor 231 (step S43).
  • the control unit 11 stops the first motor 270 and the eccentric motor 273 (step S44). As described above, when the first detection signal is input, the control unit 11 temporarily stops the drug delivery by the drug supply unit.
  • control unit 11 drives the first motor 270 in the reverse rotation direction by the set amount (step S45). In this way, when the first detection signal is input, the control unit 11 temporarily reverses the drug transport direction of the drug supply unit to the reverse direction.
  • the control unit 11 drives the first motor 270 in the reverse rotation direction by the set amount, stops the first motor 270, and returns to step S41.
  • control unit 11 terminates the supply operation of the medicines for one package (step S34).
  • FIG. 41 is a flowchart illustrating the operation of the control unit when counting the medicines supplied by the medicine supply unit.
  • the control unit 11 determines whether the first sensor 231 as the first detection unit has detected the drug. The determination is made based on the presence or absence of the input of the first detection signal from the first sensor 231 (step S51).
  • the control unit 11 turns on the arrival flag (step S52).
  • the control unit 11 leaves the arrival flag as it is.
  • control unit 11 determines whether or not the second sensor 232, which is the second detection unit, has detected the drug based on the presence or absence of the input of the second detection signal from the second sensor 232 (step S53).
  • step S53 when the second sensor 232 is detecting the drug, the drug blocks the optical axis between the light projecting unit and the light receiving unit that configure the second sensor 232.
  • step S53 the control unit 11 determines whether the second sensor 232, which is the second detection unit, detects the drug as a second detection signal from the second sensor 232. It is determined whether or not there is an input (step S54).
  • step S54 in the state where the second sensor 232 is not detecting the medicine, the medicine passes through the optical axis between the light projecting section and the light receiving section which constitute the second sensor 232, and the optical axis concerned. Is the state in which it has returned to the original open state.
  • the control unit 11 returns to step S51.
  • step S54 the control unit 11 confirms whether the arrival flag is on (step S55). When the second sensor 232 does not detect the drug in step S54, the control unit 11 returns to step S54.
  • step S54 When the second sensor 232 does not detect the drug and the arrival flag is on in step S54, the control unit 11 increments the supply number by 1 (step S56) and turns off the arrival flag (step S56). Step S57).
  • step S59 the control unit 11 determines that the drug is abnormal when the second detection signal is input a plurality of times during the input interval in which the first detection signal is input.
  • step S58 the control unit 11 determines whether the supply number is equal to or more than the required number of medicines in one package. When the supply number is equal to or more than the required number of medicines in one package, the control unit 11 finishes counting the medicines. When the supply number is less than the required number of medicines in one package, the control unit 11 returns to step S51.
  • control unit 11 receives the first detection signal from the first sensor 231, controls the medicine supply unit according to the first detection signal, and inputs the second detection signal from the second sensor 232. Then, the medicines supplied from the medicine supply unit are counted according to the second detection signal.
  • the control unit 11 controls the drug supply unit according to the drug information. Specifically, when it is determined from the drug information that the drug contained in the drug container 300 is a general drug, the general drug is supplied for each rotation amount of the drug container 300. Since the amount discharged to the portion is large, the control unit 11 stops the rotation drive of the medicine container 300 immediately after the medicine detection sensor 235 detects that there is a medicine at the medicine receiving position. After this, when the drug is no longer detected by the drug detection sensor 235, the rotation of the drug container 300 is restarted. This can prevent the medicine from being excessively supplied to the medicine supply unit.
  • the control unit 11 determines the time from the detection of the drug at the drug receiving position by the drug detection sensor 235 until the rotation drive of the drug container 300 is stopped in the case of a general drug. Make it longer than.
  • the control unit 11 increases the rotation speed of the medicine container 300 as compared with a general medicine.
  • the control unit 11 also increases the rotation speed of the rotating body 110 as compared with the case of a general medicine. By doing so, even in the case of a special drug that is difficult to be discharged by rotation drive, the time required for drug replenishment can be made closer to that of a general drug, and the drugs can be supplied one by one from the discharge unit 131.
  • each of the rotating body 110 and the vibrating portion 260 is temporarily stopped, and the rotating body 110 is temporarily reversed. Then, the medicine discharged from the discharge portion 131 is held on the slope 110s.
  • the vibrating portion 260 is temporarily stopped, the rotating body 110 is temporarily stopped, and then the medicine is discharged from the discharge portion 131.
  • the medicine to be held may be held on the slope 110s.
  • the control device unit 460 supplies the medicine next to the first medicine supplying apparatus 10 which supplies the medicine according to the packing information.
  • the medicine replenishment unit 12 starts the medicine replenishment.
  • the control device unit 460 sequentially supplies the required number of medicines in one prescription from the first medicine supplying device 10 in accordance with the packaging information, The replenishment of the medicine by the medicine replenishing unit 12 is stopped. As a result, it is possible to prevent the medicine replenishment unit 12 from replenishing the medicine supply module 100 with the medicine excessively.
  • the control device unit 460 receives the medicine detection signal from the medicine detection sensor 235, and the medicine detection sensor 235 receives the medicine detection signal according to the first detection state.
  • the drug detection sensor 235 is in the second detection state, the drug replenishment unit 12 is caused to replenish the drug.
  • the medicine can be appropriately replenished from the medicine replenishing unit 12 to the medicine supply module 100 by a simple control.
  • the control unit 11 receives the drug detection signal from the drug detection sensor 235 and controls the drug replenishment unit 12 according to the drug detection signal.
  • the control unit 11 receives the drug detection signal from the drug detection sensor 235 and controls the drug replenishment unit 12 according to the drug detection signal.
  • the control unit 11 stops the drug replenishment by the drug replenishment unit 12 when the drug detection sensor 235 is in the first detection state, and the drug detection sensor.
  • the medicine replenishing unit is made to replenish the medicine.
  • the medicine can be appropriately replenished from the medicine replenishing unit 12 to the medicine supply module 100 by a simple control.
  • the control unit 11 controls the medicine replenishment unit after the waiting time has elapsed from the time when the medicine detection sensor 235 changes from the first detection state to the second detection state. Let 12 replenish the drug. As a result, it is possible to prevent the medicine replenishment unit 12 from replenishing the medicine supply module 100 with the medicine excessively.
  • the control unit 11 sets the waiting time according to the medicine information. Thereby, the medicine can be appropriately replenished from the medicine replenishing unit 12 to the medicine supply module 100 according to the kind of the medicine.
  • the control unit 11 causes the drug replenishment unit 12 to replenish the drug when the drug detection sensor 235 changes from the second detection state to the first detection state. Stop and stop the above-mentioned time, when the operation amount of the medicine supply module 100 exceeds the set value, and when the medicine detection sensor 235 changes from the first detection state to the second detection state, the medicine is replenished later. Replenishment of the medicine by the section 12 is restarted. As a result, it is possible to prevent the medicine replenishment unit 12 from replenishing the medicine supply module 100 with the medicine excessively.
  • the control unit 11 sets the set value according to the drug information.
  • the medicine can be appropriately replenished from the medicine replenishing unit 12 to the medicine supply module 100 according to the kind of the medicine.
  • the control part 11 inputs the 1st detection signal from the 1st sensor 231, controls the chemical
  • the second detection signal is input from the second sensor 232, and the medicine supplied from the medicine supply module 100 is counted according to the second detection signal. Accordingly, even when the first sensor 231 detects a plurality of medicines in an overlapping state, the second sensor 232 detects a plurality of medicines in a separated state, and thus the plurality of medicines from the discharge unit 131 are detected. It is possible to detect that is discharged at the same time.
  • the control unit 11 when the first detection signal is input, temporarily causes the drug supply module 100 to reverse the drug transport direction. Accordingly, it is possible to prevent the plurality of medicines from being simultaneously discharged from the discharge unit 131.
  • the control unit 11 temporarily stops the drug delivery by the drug supply module 100 when the first detection signal is input. Even in this case, it is possible to prevent the plurality of medicines from being simultaneously discharged from the discharge portion 131.
  • the control unit 11 receives a drug information signal having drug information related to the shape of the drug.
  • the control unit 11 controls the medicine supply module 100 according to the medicine information.
  • the drug supply module 100 temporarily stops the drug transfer, or the drug supply module 100 temporarily reverses the drug transfer direction.
  • the control unit 11 determines which of the above is selected according to the drug information.
  • the control unit 11 determines the time to temporarily stop or the time to temporarily convey in the opposite direction according to the drug information. Accordingly, it is possible to prevent a plurality of drugs from being simultaneously discharged from the discharging unit 131 in a mode according to the type of the drug.
  • the control part 11 will judge with an abnormality, if a 2nd detection signal is input in multiple times during the input interval which a 1st detection signal is input. .. Accordingly, it is possible to detect an abnormality in which a plurality of drugs are simultaneously discharged from the discharge unit 131.

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Basic Packing Technique (AREA)

Abstract

Dans la présente invention, une unité de fourniture de médicament comprend une position de réception de médicament destinée à recevoir un médicament rechargé, aligne et transporte le médicament à partir de la position de réception de médicament et fournit individuellement le médicament dans l'ordre à partir de la tête de la ligne. Une unité de recharge de médicament recharge le médicament dans la position de réception de médicament. Une unité de détection de médicament détecte l'absence/présence du médicament dans la position de réception de médicament et délivre un signal de détection de médicament. Une unité de commande permet de commander l'unité de recharge de médicament. Le signal de détection de médicament en provenance de l'unité de détection de médicament est entré dans l'unité de commande, qui commande l'unité de recharge de médicament en réponse au signal de détection de médicament.
PCT/JP2019/047821 2019-02-04 2019-12-06 Dispositif de fourniture de médicament WO2020162020A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2019017964A JP7479037B2 (ja) 2019-02-04 2019-02-04 薬剤供給装置
JP2019-017964 2019-02-04

Publications (1)

Publication Number Publication Date
WO2020162020A1 true WO2020162020A1 (fr) 2020-08-13

Family

ID=71948210

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2019/047821 WO2020162020A1 (fr) 2019-02-04 2019-12-06 Dispositif de fourniture de médicament

Country Status (2)

Country Link
JP (2) JP7479037B2 (fr)
WO (1) WO2020162020A1 (fr)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001060726A1 (fr) * 2000-02-16 2001-08-23 Sanyo Electric Co., Ltd. Dispositif d'alimentation en produits chimiques
WO2016013553A1 (fr) * 2014-07-23 2016-01-28 株式会社湯山製作所 Cassette de médicament
JP2018500254A (ja) * 2014-12-15 2018-01-11 クリテム・カンパニー・リミテッド 薬剤包装用カセット

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001060726A1 (fr) * 2000-02-16 2001-08-23 Sanyo Electric Co., Ltd. Dispositif d'alimentation en produits chimiques
WO2016013553A1 (fr) * 2014-07-23 2016-01-28 株式会社湯山製作所 Cassette de médicament
JP2018500254A (ja) * 2014-12-15 2018-01-11 クリテム・カンパニー・リミテッド 薬剤包装用カセット

Also Published As

Publication number Publication date
JP2020124327A (ja) 2020-08-20
JP7479037B2 (ja) 2024-05-08
JP2024040510A (ja) 2024-03-25

Similar Documents

Publication Publication Date Title
JP4638793B2 (ja) 錠剤供給装置及び錠剤供給方法
JP2007314203A (ja) 錠剤供給装置
WO2020162020A1 (fr) Dispositif de fourniture de médicament
WO2020162019A1 (fr) Dispositif d'emballage de médicament
WO2020162021A1 (fr) Dispositif d'administration de médicament
JP7398838B2 (ja) 薬剤供給装置
US20170327255A1 (en) Cassette for drug packaging
JP7470451B2 (ja) 薬剤供給装置
JP7420414B2 (ja) 薬剤供給装置
JP7357406B2 (ja) 薬剤供給装置
JP7148961B2 (ja) 薬剤供給装置
JP7193128B2 (ja) 薬剤供給装置
WO2020162022A1 (fr) Dispositif d'emballage de médicament
JP2024033229A (ja) 薬剤分包装置
US20150196459A1 (en) Pill Counting and Conveying Apparatus
JP2005168743A (ja) 遊技機
JP2009023844A (ja) 略円筒状の物品の払い出し装置
JP4461851B2 (ja) コイン回転送出し機構、コイン払出し装置およびスロット遊技機

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 19914685

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 19914685

Country of ref document: EP

Kind code of ref document: A1